急性上消化道出血患者维生素C缺乏的患病率及预后意义:一项前瞻性队列研究
该前瞻性队列研究纳入227例急性上消化道出血患者,入院时检测空腹维生素C水平,维生素C缺乏定义为<23 μmol/L,严重缺乏为<12 μmol/L。维生素C缺乏者74例(32.6%),严重缺乏者32例(14.1%);维生素C缺乏与不良事件复合终点、院内死亡、住院时间延长和再出血率升高相关。多因素logistic回归显示维生素C缺乏与不良事件复合终点独立相关。作者认为需干预性研究确定早期补充维生素C对临床结局的影响。
要点
- 急性上消化道出血患者中维生素C缺乏患病率为32.6%,严重缺乏为14.1%。
- 维生素C缺乏与不良事件复合终点、院内死亡、住院时间延长和再出血率升高相关。
- 维生素C缺乏与不良事件复合终点独立相关;需干预性研究确定早期补充维生素C的影响。
核心结论
- 维生素C缺乏在急性上消化道出血患者中高度流行,并与较差结局相关,包括较高的死亡率、再出血率和住院时间延长。
- 需要干预性研究来确定早期补充维生素C对临床结局的影响。
研究设计与样本
- 前瞻性队列研究,纳入227例急性上消化道出血患者,平均年龄64.5岁,男性占63.9%。
- 入院时采集空腹维生素C水平,维生素C缺乏定义为<23 μmol/L,严重缺乏定义为<12 μmol/L。
- 主要结局为维生素C缺乏患病率及按维生素C缺乏状态分层的不良事件复合终点;次要结局为住院时间延长和需要入住ICU。
主要发现
- 维生素C缺乏者74例(32.6%),严重缺乏者32例(14.1%)。
- 与维生素C水平正常者相比,维生素C缺乏者不良事件复合终点发生率更高(45.9% vs 24.8%,p < 0.01)。
- 与维生素C水平正常者相比,维生素C缺乏者院内死亡率更高(9.5% vs 1.3%,p < 0.01)。
- 与维生素C水平正常者相比,维生素C缺乏者住院时间延长比例更高(62.2% vs 47.1%,p = 0.03)。
- 与维生素C水平正常者相比,维生素C缺乏者再出血率更高(17.6% vs 7.8%,p = 0.03)。
关键数值与推荐
- 维生素C缺乏定义为维生素C水平<23 μmol/L。
- 严重维生素C缺乏定义为维生素C水平<12 μmol/L。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vitamin C is an essential dietary nutrient important for collagen synthesis, including within the gastrointestinal tract. AIM: We aimed to document the prevalence of Vitamin C deficiency (VCD) in patients who present with upper gastrointestinal bleeding (UGIB) and its association with clinical outcomes. METHODS: We conducted a prospective cohort study of patients presenting with UGIB. Fasting Vitamin C levels were collected at admission. Primary outcomes were the prevalence of VCD (Vitamin C level <23 μmol/L, severe VCD < 12 μmol/L) and a composite outcome of adverse events, stratified by VCD status. Secondary outcomes were prolonged hospitalisation and the need for ICU admission. RESULTS: A total of 227 patients were included (mean age 64.5 years, males 63.9%). VCD was identified in 74 (32.6%) and severe deficiency in 32 (14.1%) patients. VCD was associated with a higher composite endpoint of AE (45.9% vs 24.8%, p < 0.01), higher in-hospital mortality (9.5% vs 1.3%, p < 0.01), increased prolonged admissions (62.2% versus 47.1%, p = 0.03) and increased rebleeding (17.6% vs 7.8%, p = 0.03), compared with patients with normal Vitamin C levels. Multivariate logistic regression models showed that VCD was independently associated with the composite endpoint of AE. CONCLUSION: VCD is highly prevalent in patients with UGIB and associated with poorer outcomes, including higher mortality, rebleeding and length of stay. Interventional studies are required to determine the impact of early Vitamin C supplementation on clinical outcomes.
引用
- Hui S, Lim A, Koh E, et al. Prevalence and prognostic significance of vitamin C deficiency in patients with acute upper gastrointestinal bleeding: a prospective cohort study. Aliment Pharmacol Ther. 2022. PMID: 36514851. doi:10.1111/apt.17359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。